American National Insurance’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$589K Sell
12,365
-8,973
-42% -$380K 0.16% 189
2021
Q4
$879K Sell
21,338
-120,979
-85% -$4.56M 0.19% 149
2021
Q3
$4.91M Sell
142,317
-126
-0.1% -$4.31K 0.18% 155
2021
Q2
$4.5M Sell
142,443
-218
-0.2% -$7.02K 0.17% 174
2021
Q1
$4.45M Sell
142,661
-119
-0.1% -$3.58K 0.18% 162
2020
Q4
$4.3M Hold
142,780
0.18% 150
2020
Q3
$3.64M Hold
142,780
0.18% 143
2020
Q2
$3.7M Hold
142,780
0.19% 133
2020
Q1
$3.75M Hold
142,780
0.24% 117
2019
Q4
$4.64M Hold
142,780
0.24% 118
2019
Q3
$4.92M Hold
142,780
0.26% 111
2019
Q2
$4.88M Hold
142,780
0.26% 114
2019
Q1
$5.11M Buy
+142,780
New +$4.86M 0.27% 116
2014
Q1
Sell
-50,016
Closed -$977K 351
2013
Q4
$977K Hold
50,016
0.06% 245
2013
Q3
$1.06M Sell
50,016
-4,627
-8% -$101K 0.08% 229
2013
Q2
$1.2M Buy
+54,643
New +$1.33M 0.09% 224

Other funds holding EXC

American National Insurance's EXC Position: Q1 2022 in Review

American National Insurance reduced its Exelon (EXC) stake by 42% in Q1 2022, selling an estimated $380K and leaving 12,365 shares worth $589K. The position accounts for 0.16% of the portfolio, ranked #189.

American National Insurance first reported a position in EXC in Q2 2013 and has held it in 16 quarters since. The position peaked at $5.11M in Q1 2019. 1,025 funds tracked by Wall St. Rank hold EXC as of Q1 2022.

  • American National Insurance held 12,365 shares of Exelon worth $589K as of Q1 2022.
  • American National Insurance sold 8,973 Exelon shares in Q1 2022, an estimated $380K.
  • Exelon made up 0.16% of American National Insurance's portfolio in Q1 2022, its #189 holding.
  • American National Insurance first reported a position in Exelon in Q2 2013 and has held it in 16 quarters since.
  • American National Insurance's Exelon position peaked at $5.11M in Q1 2019.
  • 1,025 funds tracked by Wall St. Rank held Exelon as of Q1 2022.

Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.